The Drug Supply Chain Security Act – DSCSA (Title II, Drug
Quality and Security Act, 2013) has been signed into law, with
full implementation phased in over the next 10 years. The next
milestone for manufacturers, November 27, 2017, is the date
by which pharmaceutical manufacturers are required to print
a unique product identification code on all Rx units of sale and
homogenous cases distributed domestically.